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 Abstract 
  Aims:   To investigate the incidence and severity of the ‘head-turning sign’ (HTS), i.e. turning the 
head back to the caregiver(s) for help, in patients with various dementias and discuss its clinical 
specificity in Alzheimer’s disease (AD).   Methods:   We investigated the incidence and severity of 
HTS while administering a short cognitive test (the revised Hasegawa Dementia Rating Scale: 
HDSR) in outpatients with AD [125 patients, including 4 with AD + vascular dementia (VaD)], 8 
with amnestic mild cognitive impairment (aMCI), 34 with dementia with Lewy bodies (DLB), 8 
with progressive supranuclear palsy (PSP) and 6 with VaD.  Results:  Significant differences were 
found among the 5 disease groups in the incidence and severity of HTS, and HDSR scores. Given 
the significant differences between AD and DLB in post hoc analyses, patients were dichoto-
mized into AD-related (AD and aMCI) and AD-nonrelated (PSP, DLB and VaD) groups. Both inci-
dence (41 vs. 17%, p = 0.002) and severity of HTS (0.80   8   1.13 vs. 0.21   8   0.60, p = 0.001) were 
significantly higher in the AD-related group, while average age and HDSR scores were compa-
rable between both groups. AD-related disease, female gender and low HDSR score contrib-
uted significantly to the occurrence and severity of HTS.   Conclusions:   HTS can be a clinical 
marker of AD and aMCI, and may represent a type of excuse behavior as well as a sign of depen-
dency on and trust in the caregivers.    Copyright © 2011 S. Karger AG, Basel 
  Published online: October 11, 2011 
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 Introduction 
  When facing questions that are beyond their cognitive capacity, patients with dementia 
may turn back to the caregiver(s) for help, as if they were asking silently for some cues or an-
swers directly to the question. This behavior, simplistically designated as ‘head-turning sign’ 
(HTS), has often observed in our patients, especially in patients with Alzheimer’s disease 
(AD), but has rarely been investigated or reported in the literature. A single description of 
HTS as a sign observed in AD is found in a paragraph of the book entitled  Clinical Diagnosis 
and Management of Alzheimer’s Disease     [1]  . A PubMed search using the key words ‘head-
turning sign’ and ‘dementia’ revealed no related articles. Therefore, it is not yet known how 
frequently HTS is observed in patients with AD at different stages of disease, and whether or 
not incidence and severity of HTS differ from those in other types of dementia. Consequent-
ly, we have little knowledge as to whether HTS is rather specific for AD or is ubiquitously 
present in the general dementia population. Furthermore, whether or not HTS correlates 
with declining cognition remains to be determined. The purpose of this study is first to in-
vestigate the incidence (frequency) and severity of HTS in AD and make comparisons with 
other dementia types and amnestic mild cognitive impairment (aMCI), and secondly to dis-
cuss whether HTS represents a clinical marker of AD and its precursor stage (aMCI), and 
finally to study the pathophysiological aspects of HTS in more detail.
  Patients  and  Methods 
 Patients 
  We studied consecutive outpatients with dementia who were treated regularly by one 
of the authors (T.F.) at the Neurology Department of the Showa University Northern Yoko-
hama Hospital in the period from September 2010 to March 2011. The study patients in-
cluded 125 with AD [including 4 with mixed vascular dementia (VaD)], 8 with aMCI, 34 
with dementia with Lewy bodies (DLB), 8 with progressive supranuclear palsy (PSP) and 6 
with VaD. The diagnosis of each disease was made based on the established diagnostic cri-
teria: AD using NINCDS-ADRDA criteria  [2] , aMCI using Petersen’s criteria  [3] , DLB using 
DLB Consortium criteria in 2005   [4]  , PSP by NINDS-SPSP (National Institute of Neuro-
logical Disorders and the Society for Progressive Supranuclear Palsy) criteria   [5]   and VaD 
using NINDS-AIREN (International Workshop of the National Institute of Neurological 
Disorders and Stroke and the Association Internationale pour la Recherche et l’Enseigne-
ment en Neurosciences) criteria   [6]  . The diagnosis of AD mixed with VaD was made when 
clinical features of AD as well as VaD, physical signs compatible with multiple vascular le-
sions and their radiological evidence all coexisted. Furthermore, in an attempt to enhance 
the specificity of the diagnosis of DLB, we included only patients who satisfied the diagnos-
tic criteria and showed abnormalities on   123  I-meta-iodobenzylguanidine (MIBG) myocar-
dial scintigraphy, which is recommended as one of the supportive diagnostic measures. We 
adopted the cutoff values of an heart/mediastinum (H/M) uptake ratio  ! 1.68 and/or a wash-
out rate   1  23.6%, which are considered to be highly sensitive and specific for the diagnosis 
of DLB   [7]  .
  M e t h o d s  
 We carefully observed whether or not the patients demonstrated HTS while administer-
ing a short cognitive test (the revised Hasegawa Dementia Rating Scale: HDSR) that usually 
takes about 10 min. The caregiver(s) was asked to be seated quietly at 45° and approximately 
1 m behind the patient. HTS was considered present only when patients turned back to their 312
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caregivers in the face of difficulties with the HDSR subitems that the patients could not deal 
with, and asked the caregivers to help them either explicitly or implicitly. Self-devoted head 
tilting when deep in thought and any head movements associated with agitation, attention 
deficits or denial were not considered as HTS. Then, we scored semiquantitatively the sever-
ity in HTS-positive patients: when patients turned back only once, a severity score of 1 was 
assigned, a score of 2 for twice, and 3 for three times or more during the HDSR session. Pa-
tients and caregivers gave informed consent for our administering of the HDSR and for ob-
serving patient behavior during the test. This study was approved by the Ethics Committee 
of the Showa University Northern Yokohama Hospital.
  S t a t i s t i c s  
  We compared the incidence of HTS (percentage of patients who demonstrated HTS) in 
each disease group, and the severity scores of HTS as well as the demography data of the pa-
tients and average HDSR scores. First, we compared the 5 disease groups using the Kruskal-
Wallis test for numerical data (age, HDSR and severity scores) and the     2   test for categorical 
data (gender and incidence of HTS).
    As the comparisons of the 5 groups and post hoc Mann-Whitney tests revealed signifi-
cant differences in both incidence and severity of HTS between AD and DLB (details in Re-
sults), we secondly dichotomized the whole patients into AD-related (AD and aMCI) and 
AD-nonrelated (DLB, PSP and VaD) groups, and compared these two groups using the 
Mann-Whitney and     2   tests.
    Lastly, to determine independent factors possibly contributing to the occurrence and 
severity of HTS, age and gender of patients, HDSR score and disease type (AD related and 
nonrelated) were analyzed using logistic (presence or absence of HTS) and linear (severity 
scores) regression analyses. A value of p   !   0.05 represented statistical significance.
  R e s u l t s  
  Comparisons among the 5 Disease Groups  
 HTS incidence and/or severity scores in AD (incidence: 42%/severity score: 0.82  8  1.13) 
and aMCI (25%/0.44   8   1.05) were higher than in DLB (15%/0.21   8   0.63), PSP (25%/0.31   8  
0.70) and VaD (17%/0.08  8  0.20;  table 1 ,  fig. 1 ,  2 ). Group comparisons revealed that both the 
incidence (p = 0.029) and severity (p = 0.014) of HTS as well as HDSR scores (p = 0.0005) dif-
fered significantly among the 5 disease groups. Differences in the average age among the 5 
Table 1.   Patient demography, average HDSR scores, and incidence and severity of HTS
Groups Age
years
Females
% 
HDSR
scores
H TS
incidenc  e, % severity scores
AD 79.188.7 65 14.586.6 42 0.8281.13
aMCI 79.384.0 63 24.883.9 25 0.4481.05
DLB 77.986.3 47 15.186.9 15 0.2180.63
PSP 78.485.2 38 14.588.0 25 0.3180.70
VaD 73.883.2 33 20.584.2 17 0.0880.20
p value 0.06 0.14 0.0005 0.029 0.014313
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groups, being apparently lower in VaD, showed a tendency toward significance (p = 0.06). 
The percentage of females was highest in AD and lowest in VaD patients, but group differ-
ences did not reach significance (p = 0.14). In post hoc analyses, significant differences in the 
incidence (p = 0.003) and severity (p = 0.003) of HTS were found between AD and DLB. The 
HDSR scores were significantly higher in aMCI than in AD, DLB and PSP (p = 0.0005–0.01), 
while they were comparable among AD, DLB and PSP. The HDSR score in VaD was signifi-
cantly higher than in AD (p = 0.03) but lower than in aMCI, with a trend toward significance 
(p = 0.06).
    As partly mentioned in the Methods, these results, together with a general conception 
that in the majority of patients aMCI is pathophysiologically a precursor of AD   [8]  , lead us 
to dichotomize the study patients into AD-related (AD and aMCI; n = 133) and AD-non-
related (PSP, DLB and VaD; n = 48) groups.
    Comparisons between AD-Related and AD-Nonrelated Groups  
  The percentage of females was significantly higher in the AD-related than in the AD-
nonrelated group (65 vs. 44%, respectively; p = 0.016), while average age (p = 0.20) and HDSR 
scores (p = 0.54) were similar between both groups (  table 2 ,   fig. 3 ,   4  ). Both incidence 
(AD related 41% and AD nonrelated 17%; p = 0.002) and severity scores of HTS (AD related 
0.80   8   1.13 and AD nonrelated 0.21   8   0.60; p = 0.001) were significantly higher in the AD-
related group.
  Fig. 1.   Age, gender distribution, 
HDSR scores and incidence of 
HTS in AD, aMCI, DLB, PSP and 
VaD.   *   p = 0.03 vs. DLB.  
  Fig. 2.   HTS severity scores of the 
5 disease groups.   *   p = 0.03 vs. 
DLB. 314
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    Factors Contributing to HTS 
 Logistic regression showed that significant and independent contributors of HTS occur-
rence included AD-related disease (odds ratio [OR] 2.98, 95% confidence interval [CI] = 
1.26–7.09, p = 0.013), female gender (OR 2.83, 95% CI = 1.39–5.75, p = 0.004) and HDSR 
scores (OR 0.94, 95% CI = 0.90–0.99, p = 0.016), explaining 18% of the variances. Similarly, 
AD-related diseases (   = 0.21, p = 0.004), female gender (   = 0.18, p = 0.015) and HDSR scores 
(     = –0.16, p = 0.018) independently predicted HTS severity scores, explaining 11% of the 
variances.
Table 2.   Patient demography, average HDSR scores, and incidence and severity of HTS between AD-
related (AD and aMCI) and AD-nonrelated (DLB, PSP and VaD) groups
Groups Age
years
Females
%
HDSR
scores
H TS
incidence,   % severity scores
AD related 79.188.5 65 15.286.8 41 0.8081.13
AD nonrelated 77.485.9 44 15.787.0 17 0.2180.60
p value 0.20 0.016 0.54 0.002 0.001
  Fig. 3.   Age, gender distribution, 
HDSR scores and incidence of 
HTS in AD-related (AD and 
aMCI) and AD-nonrelated groups 
(DLB, PSP and VaD). 
  Fig. 4.   HTS severity scores of 
AD-related and AD-nonrelated 
groups. 315
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  Discussion 
  Disease-specific signs and symptoms, despite their rather anecdotal character, are help-
ful and even essential for making accurate differential diagnoses especially when dealing 
with clinicopathologically overlapping diseases, such as AD, DLB and VaD, or PSP, cortico-
basal degeneration and frontotemporal dementia. Auxiliary diagnostic strategies represent-
ed by various imaging methods and biomarkers, such as MRI, SPECT, MIBG scintigraphy, 
amyloid imaging,     -amyloid and phosphorylated tau in cerebrospinal fluid and striatal   123 I-
FP-CIT SPECT are especially useful in differentiating AD from DLB or other diseases in the 
early phase; however, these sophisticated methods are not always available to all clinicians. 
This study addressed the importance of a single clinical sign (HTS) in the differentiation of 
AD from other dementia-causing diseases, namely DLB, PSP and VaD.
  In the current study, diagnoses were made carefully at the initial clinical assessment and 
confirmed by a long-term follow-up. Furthermore, we paid specific attention to avoiding 
confusion between DLB and AD, PSP or VaD, because the initial symptoms of DLB may be 
highly variable   [9]  . The diagnosis of DLB was made only when patients satisfied the consen-
sus criteria   [4]   and showed abnormalities on the MIBG myocardial scintigraphy that are 
considered specific for DLB   [7]  . Conversely, MIBG myocardial scintigraphy was utilized 
when the clinical differentiation between DLB and AD, PSP or VaD was difficult. When 
MIBG scintigraphy was introduced in the differential diagnosis, the diagnostic specificity 
for each disease may be higher than without it   [7]  .
    Having the clinical diagnoses made as correctly as possible, we compared the incidence 
and severity of HTS. As hypothesized at the beginning, results proved that HTS was most 
prevalent and severe in patients with AD, followed by aMCI regarding HTS severity. Both 
the frequency and the severity of HTS were significantly different among the 5 disease groups 
and post hoc analyses showed that significant differences existed between AD and DLB.
    Based on these findings as well as the fact that aMCI is most likely a prodromal stage of 
AD   [8]  , patients were grouped into AD related (AD and aMCI) and AD nonrelated (DLB, 
PSP and VaD). As expected, comparisons between these two groups showed that the inci-
dence as well as the severity scores for HTS was significantly higher in the AD-related group. 
Thus, HTS can be regarded as one of the clinical features that characterize AD and aMCI, as 
previously described   [1]  , and frequent HTS may suggest, although not conclusively, a diag-
nosis of AD or its prodromal stage (aMCI).
    What are the pathophysiological factors underlying HTS? HTS was more prevalent and 
severer in AD-related diseases that highlight memory impairment with comparatively pre-
served frontal executive function. In contrast, HTS was rarer in AD-nonrelated diseases that 
may feature more apparent dysexecutive syndromes. HTS may represent rather intact execu-
tive strategies and tactics when facing memory-related difficulties that are beyond the cogni-
tive abilities of patients. Conversely, patients with deficits in executive function, divided at-
tention or set changing may not be able to come up on the spot with an idea of turning to 
their caregivers and asking for help as an alternative strategy for coping with troubles at 
hand. From this point of view, HTS may share some properties with excuse behaviors, often 
observed in AD patients, in an attempt to cover up memory deficits.
    Concomitantly, HTS may also signify dependency on and trust in the caregivers/family 
members by shifting the responsibilities that patients are supposed to carry. Analysis of be-
haviors of patients with AD showed an extremely high incidence rate of dependency (87% of 
106 patients with probable AD) together with denial of illness (63%) and motor agitation 
(55%)   [10] .
    Independent of the epidemiological fact that AD is more prevalent in females, female 
gender was a statistically significant contributor to HTS. In general, women may feel easier 316
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at heart to become dependent on others when facing difficulties, while men tend to feel ob-
ligated to deal with adversities without help. In fact, a recent study compared the prevalence 
of behavioral and psychological symptoms of dementia in men and women with cognitive 
impairment and showed that ‘help seeking’ and depression were significantly more frequent 
in women, while aggressive and regressive behaviors were more prevalent in men   [11]  . HTS 
is essentially a behavior of help seeking and the finding from the current study that HTS is 
more frequent in women may strengthen a previous finding that help seeking was more 
prevalent in female patients.
    HTS turned out to be negatively but weakly associated with HDSR scores: higher inci-
dence and severity scores were associated with lower HDSR scores (OR  !  1.0 for the presence 
of HTS and a negative      for the severity of HTS). Incidence and severity of HTS may corre-
late with the severity of dementia because memory impairment that triggers HTS may wors-
en as dementia progresses. In fact, a recent large-scale survey targeting 3,404 people with 
cognitive impairment suggested that behavioral and psychological symptoms of dementia in 
general correlated negatively with the level of cognition. However, some of these symptoms, 
e.g. attention-seeking behavior (help seeking), showed non-linear correlations, with the 
highest prevalence in middle-stage cognitive impairment   [12]  . Likewise, the incidence and 
severity of HTS correlated essentially with the levels of cognitive impairment measured by 
HDSR. However, HTS was unique in that its severity score was higher in aMCI in spite of 
significantly higher HDSR scores than in PSP, DLB and VaD. In patients with aMCI, al-
though HDSR scores remain higher, the severity of memory deficits is far beyond that of 
other cognitive domains, including executive function, a situation that may elicit HTS. Giv-
en the same HDSR score, frontal executive dysfunction may be milder than memory deficits 
in an AD-related population, while the reverse may be true in AD-nonrelated diseases. As 
suggested above, HTS may be the consequence of imbalance between memory impairment 
and relatively preserved executive function.
  L i m i t a t i o n s  
  However, this study has some limitations. First, the numbers of patients in the 5 disease 
groups are not uniform because consecutive regularly visiting patients were studied. The 
numbers of patients may represent the prevalence of each disease in our dementia clinic. 
However, comparisons between AD-related (n = 133) and -nonrelated patients (n = 48) may 
be justified because it is generally understood that a sample-size difference smaller than 3:    1 
(2.8:     1 in the present study) may be compatible with statistical procedures and would not re-
duce statistical robustness   [13]  . Thus, the results obtained from AD-related and -nonrelated 
groups may be considered statistically robust. Secondly, the incidence of HTS may vary de-
pending on the persons who accompany the patients: husband, wife, children, siblings or 
professional caregivers. Because the majority of caregivers were spouses or children, the lev-
els of familiarity between a patient and the caregiver(s) was supposedly similar from patient 
to patient. Regrettably, we could not take this factor into consideration since precise infor-
mation was not available. 
  Conclusion 
  In spite of these shortcomings, the present study proposed that HTS, reflecting intact 
tactics as well as dependency and reliance on the caregivers when facing difficulties, may be 
one of the distinguishing clinical signs of AD-related cognitive impairment.317
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